New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Nektar Therapeutics (NASDAQ:NKTR), Organovo Holdings Inc (NYSEMKT:ONVO), Sequenom, Inc. (NASDAQ:SQNM), Medivation Inc (NASDAQ:MDVN)
Nektar Therapeutics (NASDAQ:NKTR) declined -2.79%, trading on 2.18 million shares, to end the trade at $13.60. If we look at its trading history of the past 52 weeks, the share price suffered a low of $8.46 and was moved to the maximum level of $14.47. The stock changed hands in a range of $13.36 to $13.78, bringing its market capitalization to about $1.70 billion. Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is consisted of early to late stage drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology.
Has NKTR Found The Bottom and Ready To Move Up? Find Out Here
Organovo Holdings Inc (NYSEMKT:ONVO) declined -3.37%, to complete the trading session at $9.45, with a total volume of 2.16 million shares. The stock, on average, trades on a volume of 4.71 million shares. In the past 52 weeks, the share price has not declined below $3.27 and above $13.65. It floated in a range of $9.11 to $9.64 during the last trading session. Its market capitalization now moved to about $730.28 million. Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs.
Has ONVO Found The Bottom And Ready To Gain Momentum? Find Out Here
Sequenom, Inc. (NASDAQ:SQNM) recorded a fall of -0.87% and was in a range of $2.22-$2.38 before closing at $2.27. The share price hit its 52-week low of $1.65 and $4.90 was the best price. The stock completed the day with a total volume of 2.11 million shares, versus an average volume of 2.04 million shares. Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.
Why Should Investors Buy SQNM After the Recent Fall? Just Go Here and Find Out
Medivation Inc (NASDAQ:MDVN) declined -1.89% yesterday, bringing its market capitalization around $6.01 billion. The total number of shares that changed hands during the session was 2.07 million shares, as compared to average trading volume of 1.34 million shares. The share price, after opening at $79.94, made a high of $81.74 and hovered above $78.75 to end the day at $79.60. Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies. The Company advanced program XTANDI (enzalutamide) capsules, or XTANDI, is partnered with Astellas Pharma Inc. ( Astellas).
Will MDVN Get Buyers Even After The Recent Rally? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)